In 2024, the global Lisinopril API Market was valued at approximately USD 680 million and is expected to reach USD 920 million by 2032, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2025 to 2032. The United States market alone was valued at USD 220 million in 2024 and is projected to grow to USD 290 million by 2032, with a CAGR of 3.5% during the forecast period. Lisinopril API (..
